Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery
Status:
Completed
Trial end date:
2024-05-15
Target enrollment:
Participant gender:
Summary
This is a multicenter, double-masked, randomized, vehicle-controlled, parallel-comparison
study conducted at sites in the United States (US) in subjects undergoing routine unilateral
cataract extraction and lens replacement (CELR) surgery via phacoemulsification